Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02366832 · ClinicalTrials.gov registry record · NA
Cryoablation for Phantom Limb Pain
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02366832: Completed NA study, sponsored by Emory University.
NCT02366832 is a NA study that has completed, run by Emory University. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02366832, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if treatment with percutaneous cryoablation yields significant differences in the evaluative criteria of Phantom Limb Syndrome (PLS).
Primary Outcome
Feasibility, defined by number of participants, in which cryoablation was performed successfully
Interventions
- PROCEDURE Cryoablation
- DEVICE 17g Galil Medical Ice Sphere cryoablation needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-12-16 |
| Phase | NA |
What the finished NCT02366832 record still lists
NCT02366832 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Cryoablation is the first listed.
NCT02366832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02366832 about?
NCT02366832 is a clinical study titled "Cryoablation for Phantom Limb Pain". The purpose of this study is to determine if treatment with percutaneous cryoablation yields significant differences in the evaluative criteria of Phantom Limb Syndrome (PLS).
What is the current status of trial NCT02366832?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2015-02. Estimated completion is 2016-12-16.
What interventions are being tested in trial NCT02366832?
The interventions under investigation include: Cryoablation (PROCEDURE), 17g Galil Medical Ice Sphere cryoablation needle (DEVICE).
Who is sponsoring clinical trial NCT02366832?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02366832's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia